Literature DB >> 25986909

Tigecycline for carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit.

Konstantinos Z Vardakas1, Dimitrios K Matthaiou, Matthew E Falagas, Elli Antypa, Asimoula Koteli, Eleni Antoniadou.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25986909     DOI: 10.3109/23744235.2015.1049659

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


× No keyword cloud information.
  5 in total

Review 1.  Fosfomycin.

Authors:  Matthew E Falagas; Evridiki K Vouloumanou; George Samonis; Konstantinos Z Vardakas
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

Review 2.  Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-Analysis.

Authors:  Wentao Ni; Yuliang Han; Jie Liu; Chuanqi Wei; Jin Zhao; Junchang Cui; Rui Wang; Youning Liu
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

3.  Optimal empiric treatment for KPC-2-producing Klebsiella pneumoniae infections in critically ill patients with normal or decreased renal function using Monte Carlo simulation.

Authors:  Guoan Wang; Wei Yu; Yushan Cui; Qingyi Shi; Chen Huang; Yonghong Xiao
Journal:  BMC Infect Dis       Date:  2021-03-26       Impact factor: 3.090

4.  Infections due to Carbapenem Resistant Enterobacteriaceae among Saudi Arabian Hospitalized Patients: A Matched Case-Control Study.

Authors:  M A Garbati; H Sakkijha; A Abushaheen
Journal:  Biomed Res Int       Date:  2016-04-06       Impact factor: 3.411

5.  Mortality, clinical and microbiological response following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections (a meta-analysis dataset).

Authors:  Akosua A Agyeman; Phillip J Bergen; Gauri G Rao; Roger L Nation; Cornelia B Landersdorfer
Journal:  Data Brief       Date:  2019-11-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.